Cargando…
Factors affecting platinum concentrations in human surgical tumour specimens after cisplatin.
We assessed factors which affect cisplatin concentrations in human surgical tumour specimens. Cisplatin 10 mg m-2 was given i.v. to 45 consenting patients undergoing surgical resection of neoplasms, and platinum was assayed in resected tumour and in deproteinated plasma by flameless atomic absorptio...
Autores principales: | Stewart, D. J., Molepo, J. M., Green, R. M., Montpetit, V. A., Hugenholtz, H., Lamothe, A., Mikhael, N. Z., Redmond, M. D., Gadia, M., Goel, R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033659/ https://www.ncbi.nlm.nih.gov/pubmed/7880744 |
Ejemplares similares
-
Pressure tuning infrared spectroscopic study of cisplatin-induced structural changes in a phosphatidylserine model membrane.
por: Taylor, K. D., et al.
Publicado: (1995) -
Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin
por: C̆emaz̆ar, M, et al.
Publicado: (1999) -
Cisplatin and platinum pharmacokinetics during hyperthermic isolated limb perfusion for human tumours of the extremities.
por: Guchelaar, H. J., et al.
Publicado: (1992) -
Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
por: Guancial, Elizabeth A., et al.
Publicado: (2016) -
A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts
por: Pratesi, G, et al.
Publicado: (1999)